Yamada, Y <br/><br/>
Ataxia telangiectasia associated with B-cell lymphoma: the effect of a half-dose of the drugs administered according to the acute lymphoblastic leukemia standard risk protocol.  [electronic resource] 

 -  Pediatric hematology and oncology   
 - 425-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0888-0018 
<br/><br/><label>Standard No.: </label>10.3109/08880019809016571  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Ataxia Telangiectasia--drug therapy<br/>Dose-Response Relationship, Drug<br/>Genes, Recessive<br/>Humans<br/>Infant<br/>Lymphoma, B-Cell--drug therapy<br/>Male<br/>Precursor Cell Lymphoblastic Leukemia-Lymphoma--drug therapy<br/>Remission Induction--methods<br/>Risk Factors